A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells
Yun Yang(Tongji University), Shuyan Duan(Xinxiang Medical University)
Cited by 7
Related Papers
The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancers
|Heliyon|2022|23
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer
|Biochemical and Biophysical Research Communications|2016|18